Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 1989 Aug 15;262(1):313–319. doi: 10.1042/bj2620313

Regulation of very-low-density-lipoprotein lipid secretion in hepatocyte cultures derived from diabetic animals.

J M Duerden 1, S M Bartlett 1, G F Gibbons 1
PMCID: PMC1133262  PMID: 2684155

Abstract

Hepatocytes were derived from 2-3-day streptozotocin-diabetic rats and maintained in culture for up to 3 days. Compared with similar cultures from normal animals, these hepatocytes secreted less very-low-density-lipoprotein (VLDL) triacylglycerol, but the decrease in the secretion of VLDL non-esterified and esterified cholesterol was not so pronounced. This resulted in the secretion of relatively cholesterol-rich VLDL particles by the diabetic hepatocytes. Addition of insulin for a relatively short period (24 h) further decreased the low rates of VLDL triacylglycerol secretion from the diabetic hepatocytes. The secretion of VLDL esterified and non-esterified cholesterol also declined. These changes occurred irrespective of whether or not exogenous fatty acids were present in the culture medium. Little or no inhibitory effect of insulin was observed after longer-term (24-48 h) exposure to the hormone. Both dexamethasone and a mixture of lipogenic precursors (lactate plus pyruvate) stimulated VLDL triacylglycerol and cholesterol secretion, but not to the levels observed in hepatocytes from normal animals. The low rate of hepatic VLDL secretion in diabetes contrasts with the increase in whole-body VLDL production rate. This suggests that the intestine is a major source of plasma VLDL in insulin-deficient diabetes.

Full text

PDF
313

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alcindor L. G., Infante R., Soler-Argilaga C., Polonovski J. Effect of a single insulin administration on the hepatic release of triglycerides into the plasma. Biochim Biophys Acta. 1973 Jun 21;306(3):347–352. doi: 10.1016/0005-2760(73)90173-2. [DOI] [PubMed] [Google Scholar]
  2. Arbeeny C. M., Edelstein D., Freedman S. R., Eder H. A. Serum lipoproteins of diabetic rats fed a high cholesterol diet. Diabetes. 1980 Oct;29(10):774–777. doi: 10.2337/diacare.20.10.774. [DOI] [PubMed] [Google Scholar]
  3. Arbeeny C. M., Eder H. A. Effect of diabetes on the metabolism of triacylglycerol-rich lipoproteins. Biochem Soc Trans. 1989 Feb;17(1):51–53. doi: 10.1042/bst0170051. [DOI] [PubMed] [Google Scholar]
  4. Bagdade J. D., Porte D., Jr, Bierman E. L. Diabetic lipemia. A form of acquired fat-induced lipemia. N Engl J Med. 1967 Feb 23;276(8):427–433. doi: 10.1056/NEJM196702232760802. [DOI] [PubMed] [Google Scholar]
  5. Bartlett S. M., Gibbons G. F. Short- and longer-term regulation of very-low-density lipoprotein secretion by insulin, dexamethasone and lipogenic substrates in cultured hepatocytes. A biphasic effect of insulin. Biochem J. 1988 Jan 1;249(1):37–43. doi: 10.1042/bj2490037. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Berry E. M., Ziv E., Bar-On H. Lipoprotein secretion by isolated perfused livers from streptozotocin-diabetic rats. Diabetologia. 1981 Oct;21(4):402–408. doi: 10.1007/BF00252689. [DOI] [PubMed] [Google Scholar]
  7. Bierman E. L., Amaral J. A., Belknap B. H. Hyperlipemia and diabetes mellitus. Diabetes. 1966 Sep;15(9):675–679. doi: 10.2337/diab.15.9.675. [DOI] [PubMed] [Google Scholar]
  8. Boyd M. E., Albright E. B., Foster D. W., McGarry J. D. In vitro reversal of the fasting state of liver metabolism in the rat. Reevaluation of the roles of insulin and glucose. J Clin Invest. 1981 Jul;68(1):142–152. doi: 10.1172/JCI110230. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Brindley D. N. Regulation of hepatic triacylglycerol synthesis and lipoprotein metabolism by glucocorticoids. Clin Sci (Lond) 1981 Aug;61(2):129–133. doi: 10.1042/cs0610129. [DOI] [PubMed] [Google Scholar]
  10. Davis R. A., Boogaerts J. R. Intrahepatic assembly of very low density lipoproteins. Effect of fatty acids on triacylglycerol and apolipoprotein synthesis. J Biol Chem. 1982 Sep 25;257(18):10908–10913. [PubMed] [Google Scholar]
  11. Duerden J. M., Gibbons G. F. Secretion and storage of newly synthesized hepatic triacylglycerol fatty acids in vivo in different nutritional states and in diabetes. Biochem J. 1988 Nov 1;255(3):929–935. doi: 10.1042/bj2550929. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Durrington P. N., Newton R. S., Weinstein D. B., Steinberg D. Effects of insulin and glucose on very low density lipoprotein triglyceride secretion by cultured rat hepatocytes. J Clin Invest. 1982 Jul;70(1):63–73. doi: 10.1172/JCI110604. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. FOLCH J., LEES M., SLOANE STANLEY G. H. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem. 1957 May;226(1):497–509. [PubMed] [Google Scholar]
  14. Fielding C. J., Reaven G. M., Liu G., Fielding P. E. Increased free cholesterol in plasma low and very low density lipoproteins in non-insulin-dependent diabetes mellitus: its role in the inhibition of cholesteryl ester transfer. Proc Natl Acad Sci U S A. 1984 Apr;81(8):2512–2516. doi: 10.1073/pnas.81.8.2512. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Gerich J. E., Langlois M., Noacco C., Lorenzi M., Karam J. H., Korsham P. H. Comparison of the suppressive effects of elevated plasma glucose and free fatty acid levels on glucagon secretion in normal and insulin-dependent diabetic subjects. Evidence for selective alpha-cell insensitivity to glucose in diabetes mellitus. J Clin Invest. 1976 Aug;58(2):320–325. doi: 10.1172/JCI108475. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Gibbons G. F. Hyperlipidaemia of diabetes. Clin Sci (Lond) 1986 Nov;71(5):477–486. doi: 10.1042/cs0710477. [DOI] [PubMed] [Google Scholar]
  17. Gibbons G. F. Insulin, diabetes and hepatic very-low-density lipoprotein metabolism. Biochem Soc Trans. 1989 Feb;17(1):49–51. doi: 10.1042/bst0170049. [DOI] [PubMed] [Google Scholar]
  18. Gibbons G. F., Pullinger C. R., Björnsson O. G. Changes in the sensitivity of lipogenesis in rat hepatocytes to hormones and precursors over the diurnal cycle and during longer-term starvation of donor animals. J Lipid Res. 1984 Dec 1;25(12):1358–1367. [PubMed] [Google Scholar]
  19. Gibbons G. F., Pullinger C. R. Regulation of hepatic very-low-density lipoprotein secretion in rats fed on a diet high in unsaturated fat. Biochem J. 1987 Apr 15;243(2):487–492. doi: 10.1042/bj2430487. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Goh E. H., Heimberg M. Relationship between activity of hepatic 3-hydroxy-3-methylglutaryl-coenzyme A reductase and secretion of very-low-density-lipoprotein cholesterol by the isolated perfused liver and in the intact rat. Biochem J. 1979 Oct 15;184(1):1–6. doi: 10.1042/bj1840001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Greenfield M., Kolterman O., Olefsky J., Reaven G. M. Mechanism of hypertriglyceridaemia in diabetic patients with fasting hyperglycaemia. Diabetologia. 1980 Jun;18(6):441–446. doi: 10.1007/BF00261698. [DOI] [PubMed] [Google Scholar]
  22. Holt P. R., Dominguez A. A. Triton-induced hyperlipidemia: a model for studies of intestinal lipoprotein production. Am J Physiol. 1980 May;238(5):G453–G457. doi: 10.1152/ajpgi.1980.238.5.G453. [DOI] [PubMed] [Google Scholar]
  23. Howard B. V. Lipoprotein metabolism in diabetes mellitus. J Lipid Res. 1987 Jun;28(6):613–628. [PubMed] [Google Scholar]
  24. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  25. Mangiapane E. H., Brindley D. N. Effects of dexamethasone and insulin on the synthesis of triacylglycerols and phosphatidylcholine and the secretion of very-low-density lipoproteins and lysophosphatidylcholine by monolayer cultures of rat hepatocytes. Biochem J. 1986 Jan 1;233(1):151–160. doi: 10.1042/bj2330151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Marsh J. B. Hepatic lipoprotein biosynthesis. Methods Enzymol. 1986;129:498–519. doi: 10.1016/0076-6879(86)29088-6. [DOI] [PubMed] [Google Scholar]
  27. Nikkilä E. A., Huttunen J. K., Ehnholm C. Postheparin plasma lipoprotein lipase and hepatic lipase in diabetes mellitus. Relationship to plasma triglyceride metabolism. Diabetes. 1977 Jan;26(1):11–21. doi: 10.2337/diab.26.1.11. [DOI] [PubMed] [Google Scholar]
  28. Nikkilä E. A., Kekki M. Plasma triglyceride transport kinetics in diabetes mellitus. Metabolism. 1973 Jan;22(1):1–22. doi: 10.1016/0026-0495(73)90024-3. [DOI] [PubMed] [Google Scholar]
  29. O'Looney P., Irwin D., Briscoe P., Vahouny G. V. Lipoprotein composition as a component in the lipoprotein clearance defect in experimental diabetes. J Biol Chem. 1985 Jan 10;260(1):428–432. [PubMed] [Google Scholar]
  30. Patsch W., Franz S., Schonfeld G. Role of insulin in lipoprotein secretion by cultured rat hepatocytes. J Clin Invest. 1983 May;71(5):1161–1174. doi: 10.1172/JCI110865. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Patsch W., Gotto A. M., Jr, Patsch J. R. Effects of insulin on lipoprotein secretion in rat hepatocyte cultures. The role of the insulin receptor. J Biol Chem. 1986 Jul 25;261(21):9603–9606. [PubMed] [Google Scholar]
  32. Popper D. A., Shiau Y. F., Reed M. Role of small intestine in pathogenesis of hyperlipidemia in diabetic rats. Am J Physiol. 1985 Aug;249(2 Pt 1):G161–G167. doi: 10.1152/ajpgi.1985.249.2.G161. [DOI] [PubMed] [Google Scholar]
  33. Pullinger C. R., Gibbons G. F. Effects of hormones and pyruvate on the rates of secretion of very-low-density lipoprotein triacylglycerol and cholesterol by rat hepatocytes. Biochim Biophys Acta. 1985 Jan 9;833(1):44–51. doi: 10.1016/0005-2760(85)90251-6. [DOI] [PubMed] [Google Scholar]
  34. Reaven E. P., Reaven G. M. Mechanisms for development of diabetic hypertriglyceridemia in streptozotocin-treated rats. Effect of diet and duration of insulin deficiency. J Clin Invest. 1974 Nov;54(5):1167–1178. doi: 10.1172/JCI107860. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Reaven G. M., Greenfield M. S. Diabetic hypertriglyceridemia: evidence for three clinical syndromes. Diabetes. 1981;30(Suppl 2):66–75. doi: 10.2337/diab.30.2.s66. [DOI] [PubMed] [Google Scholar]
  36. Reaven G. M., Mondon C. E. Effect of in vivo plasma insulin levels on the relationship between perfusate free fatty acid concentration and triglyceride secretion by perfused rat livers. Horm Metab Res. 1984 May;16(5):230–232. doi: 10.1055/s-2007-1014753. [DOI] [PubMed] [Google Scholar]
  37. Risser T. R., Reaven G. M., Reaven E. P. Intestinal contribution to secretion of very low density lipoproteins into plasma. Am J Physiol. 1978 Mar;234(3):E277–E281. doi: 10.1152/ajpendo.1978.234.3.E277. [DOI] [PubMed] [Google Scholar]
  38. Risser T. R., Reaven G. M., Reaven E. P. Intestinal very low density lipoprotein secretion in insulin-deficient rats. Diabetes. 1978 Sep;27(9):902–908. doi: 10.2337/diab.27.9.902. [DOI] [PubMed] [Google Scholar]
  39. Salmon D. M., Bowen N. L., Hems D. A. Synthesis of fatty acids in the perused mouse liver. Biochem J. 1974 Sep;142(3):611–618. doi: 10.1042/bj1420611. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Schein P. S., Alberti K. G., Williamson D. H. Effects of streptozotocin on carbohydrate and lipid metabolism in the rat. Endocrinology. 1971 Sep;89(3):827–834. doi: 10.1210/endo-89-3-827. [DOI] [PubMed] [Google Scholar]
  41. Schonfeld G. Diabetes, lipoproteins, and atherosclerosis. Metabolism. 1985 Dec;34(12 Suppl 1):45–50. doi: 10.1016/s0026-0495(85)80009-3. [DOI] [PubMed] [Google Scholar]
  42. Schonfeld G. Lipoproteins and atherosclerosis in diabetes mellitus. Biochem Soc Trans. 1989 Feb;17(1):53–55. doi: 10.1042/bst0170053. [DOI] [PubMed] [Google Scholar]
  43. Sparks C. E., Sparks J. D., Bolognino M., Salhanick A., Strumph P. S., Amatruda J. M. Insulin effects on apolipoprotein B lipoprotein synthesis and secretion by primary cultures of rat hepatocytes. Metabolism. 1986 Dec;35(12):1128–1136. doi: 10.1016/0026-0495(86)90026-0. [DOI] [PubMed] [Google Scholar]
  44. Sparks J. D., Sparks C. E., Bolognino M., Roncone A. M., Jackson T. K., Amatruda J. M. Effects of nonketotic streptozotocin diabetes on apolipoprotein B synthesis and secretion by primary cultures of rat hepatocytes. J Clin Invest. 1988 Jul;82(1):37–43. doi: 10.1172/JCI113597. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Steiner G., Poapst M. E., Shumak S. L., Foster D. M. Metabolism of the apolipoprotein B-containing lipoproteins. Methods Enzymol. 1986;129:395–420. doi: 10.1016/0076-6879(86)29082-5. [DOI] [PubMed] [Google Scholar]
  46. Taskinen M. R., Nikkilä E. A., Nousiainen R., Gordin A. Lipoprotein lipase activity in adipose tissue and skeletal muscle of human diabetics during insulin deprivation and restoration. Scand J Clin Lab Invest. 1981 May;41(3):263–268. doi: 10.3109/00365518109092043. [DOI] [PubMed] [Google Scholar]
  47. Taylor R., Agius L. The biochemistry of diabetes. Biochem J. 1988 Mar 15;250(3):625–640. doi: 10.1042/bj2500625. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Topping D. L., Mayes P. A. Insulin and non-esterified fatty acids. Acute regulators of lipogenesis in perfused rat liver. Biochem J. 1982 May 15;204(2):433–439. doi: 10.1042/bj2040433. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Unger R. H., Orci L. Physiology and pathophysiology of glucagon. Physiol Rev. 1976 Oct;56(4):778–826. doi: 10.1152/physrev.1976.56.4.778. [DOI] [PubMed] [Google Scholar]
  50. Unger R. H. The Banting Memorial Lecture 1975. Diabetes and the alpha cell. Diabetes. 1976 Feb;25(2):136–151. doi: 10.2337/diab.25.2.136. [DOI] [PubMed] [Google Scholar]
  51. Vogelberg K. H., Gries F. A., Moschinski D. Hepatic production of VLDL-triglycerides. Dependence of portal substrate and insulin concentration. Horm Metab Res. 1980 Dec;12(12):688–694. doi: 10.1055/s-2007-999233. [DOI] [PubMed] [Google Scholar]
  52. Weiland D., Mondon C. E., Reaven G. M. Evidence for multiple causality in the development of diabetic hypertriglyceridaemia. Diabetologia. 1980 Apr;18(4):335–340. doi: 10.1007/BF00251016. [DOI] [PubMed] [Google Scholar]
  53. Weisweiler P., Drosner M., Schwandt P. Dietary effects on very low-density lipoproteins in type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. 1982 Aug;23(2):101–103. doi: 10.1007/BF01271168. [DOI] [PubMed] [Google Scholar]
  54. Wilcox H. G., Dishmon G., Helmberg M. Hepatic lipid metabolism in experimental diabetes. IV. Incorporation of amino acid 14-C into lipoprotein-protein and triglyceride. J Biol Chem. 1968 Feb 10;243(3):666–675. [PubMed] [Google Scholar]
  55. Woodside W. F., Heimberg M. Effects of anti-insulin serum, insulin, and glucose on output of triglycerides and on ketogenesis by the perfused rat liver. J Biol Chem. 1976 Jan 10;251(1):13–23. [PubMed] [Google Scholar]
  56. Yamamoto M., Yamamoto I., Tanaka Y., Ontko J. A. Fatty acid metabolism and lipid secretion by perfused livers from rats fed laboratory stock and sucrose-rich diets. J Lipid Res. 1987 Oct;28(10):1156–1165. [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES